According to Yahoo!Finance, “Aradigm Corporation (ARDM), a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Its lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq and Lipoquin that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis, cystic fibrosis, and non-tuberculosis mycobacterium.”
The Study of Failure
"Low ambition offends Americans even more than low achievement." —Scott Sandage, Born Losers: A History of Failure in America